Defeat Duchenne Canada is committed to bringing the latest in Duchenne muscular dystrophy research and drug development to you – our Canadian Duchenne community. Complete the Registration Form below to receive the link.

Webinar Series: Industry Partner Update from Solid Biosciences

Join us Wednesday, November 13 at 1 p.m. ET, for the latest information from Solid Biosciences during their free webinar: INSPIRE DUCHENNE Community Update. The Solid Biosciences team will present an update on the INSPIRE DUCHENNE clinical trial for SGT-003, a next-generation microdystrophin gene therapy for individuals living with Duchenne muscular dystrophy.

Presented by:

• Annie Ganot, Vice President, Patient Advocacy
• Matthew Harmelink, M.D., Medical Director and Therapeutic Head, Neuromuscular
• Patrick Gonzalez, Ph.D., Senior Director, Clinical Science

Complete the Registration Form below to receive the link.